Welcome to Cell Medica

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer and infectious diseases.

About

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer and immune reconstitution following hematopoietic stem cell transplant.

Read More...

News

Cell Medica announces the appointment of Luis Borges, PhD, as Chief Scientific Officer

Read More...

Cell Medica acquires WT1 cancer immunotherapy from Cell and Gene Therapy Catapult

Read More...

Investment for Advanced Therapies Summit – Next Generation Cellular Immunotherapy

Read More...

Products

As a company, we are committed to making the widespread use of cellular immunotherapy in the fight against cancer and viral infections a reality. We are doing this by developing an industry leading pipeline of naturally occurring and gene-modified immune cell products that can meet medical need.

Read More...